ClinicalTrials.Veeva

Menu

Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?

A

Assiut University

Status

Enrolling

Conditions

Prosthetic Valve Endocarditis

Treatments

Drug: Aminoglycoside

Study type

Observational

Funder types

Other

Identifiers

NCT05455788
AssiutMedic

Details and patient eligibility

About

Follow-up of patients undergoing cardiac valve replacements with prosthetic valve after injection of sewing ring of prosthetic valve with aminoglycoside for prevention of infective endocarditis.

Enrollment

300 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients who need cardiac valve replacement for rheumatic or degenerative causes

Exclusion criteria

  • Patients undergoing open heart surgery for any cause other than valve replacement
  • patients who are younger than 20 years old.
  • Patients undergoing valve repair.

Trial design

300 participants in 1 patient group

Patients undergoing Cardiac valve replacement
Treatment:
Drug: Aminoglycoside

Trial contacts and locations

1

Loading...

Central trial contact

Amr I Osman; Kareem A Hosny

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems